ARMP · Armata Pharmaceuticals, Inc.
$4.56
-0.26 (-5.39%)
At close · Aug 14
Going-concern doubt
— flagged Aug 12, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These circumstances raise substantial doubt about the Company’s ability to continue as a going concern. While management believes this plan to raise additional funds will alleviate the conditions that raise substantial doubt, these plans are not entirely within our control and cannot be assessed as being probable of occurring.”View the 10-Q filed Aug 12, 2026
Market Cap
$169.55M
Shares
37.18M
Fails to deliver — shares from a trade that were not delivered to the buyer by the settlement date — published by the SEC twice a month. Persistent fails can reflect settlement problems or naked short selling.
Fails to Deliver History
| Settlement Date | Quantity | Price | Value |
|---|---|---|---|
| 2026-07-02 | 1,239 | $5.88 | $7,285 |
| 2026-06-26 | 7 | $6.50 | $46 |
| 2026-06-24 | 10,367 | $7.01 | $72,673 |
| 2026-06-22 | 308 | $7.08 | $2,181 |
| 2026-06-15 | 3,950 | $7.58 | $29,941 |
| 2026-06-12 | 1,128 | $7.47 | $8,426 |
| 2026-06-10 | 37,362 | $7.78 | $290,676 |
| 2026-06-08 | 831 | $7.50 | $6,233 |
| 2026-06-05 | 134 | $7.69 | $1,030 |
| 2026-06-01 | 344 | $8.17 | $2,810 |
| 2026-05-20 | 19,582 | $8.46 | $165,664 |
| 2026-05-19 | 20,645 | $7.60 | $156,902 |
| 2026-05-18 | 53 | $8.05 | $427 |
Showing 1–13 of 13 settlements
Key facts
CIK
921114
CUSIP
04216R102
13F (30d)
51 filings
51 filers
Visit website
Investor relations